OBIO
Orchestra BioMed Holdings, Inc.
NASDAQ · USHealthcareBiotechnology
$3.66-0.54%
Price as of Jul 20, 2026
OBIO earnings
Orchestra BioMed Holdings, Inc. earnings
Reported EPS and revenue history, upcoming estimates and available earnings-call summaries.
Next earnings
Aug 11, 2026in NaN days
EPS est $-0.35 · Revenue est $137714
Track record
Beat EPS in 7 of 9 quarters
Avg surprise +47.1% (last 4 quarters)
Earnings history
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| May 12, 2026 | $-0.40 | $-0.33 | +17.5% | $110000 | -88.0% |
| Mar 12, 2026 | $-0.38 | $0.26 | +168.8% | $31M | +3220.8% |
| Aug 12, 2025 | $-0.51 | $-0.50 | +2.0% | $836000 | +7.3% |
| Apr 2, 2025 | $-0.43 | $-0.43 | +0.0% | $253000 | -51.6% |
| Mar 26, 2025 | $-0.43 | $-0.37 | +14.0% | $253000 | — |
| Nov 13, 2023 | $-0.39 | $-0.38 | +2.6% | $419000 | -53.2% |
| Aug 10, 2023 | $-0.42 | $-0.35 | +16.7% | $915000 | +29.6% |
| May 12, 2023 | $-0.28 | $-0.40 | -42.9% | $1M | +71.2% |
| Jan 24, 2023 | $-0.43 | $-0.08 | +81.8% | $1M | +55.4% |
| Dec 16, 2022 | — | $-0.05 | — | $1M | — |
| Mar 31, 2022 | — | $-0.18 | — | $866000 | — |
Earnings history is derived from company filings and calendar data. Call summaries are grouped by reporting period. Latest covered event: 2026-08-11.